EU legal claim against AstraZeneca in Brussels court

<div id=”js-article__body” itemprop=”articleBody” data-sbid=”WP-MKTW-0000249171″>

The European Union’s lawsuit against AstraZeneca, the British-Swedish pharmaceutical group and developer of the world’s most widely used COVID-19 vaccine, began to be heard by a Brussels court on Wednesday under an emergency procedure. The European Commission, the EU’s executive body, accuses AstraZeneca AZN, -0.53% AZN, -0.71% of not fulfilling its contract to deliver 300 million doses of vaccines by the end of June, and alleges that the company has no a credible plan to deal with stock-outs and delays that have affected your operations. AstraZeneca only delivered 30 million of the 120 million promised in the first quarter. It says its only legal restriction was to make its “best efforts” to administer the doses, and that it has no obligation to deliver to the EU the doses manufactured in the rest of the world. The bitter dispute has influenced the delay of vaccination campaigns in the EU, where only 8% of the total population is now fully vaccinated, compared to 29% in the US and 19% in the UK. The one-hour hearing on Wednesday will be followed. for two similar sessions on May 26, and the judge hopes to issue a ruling by the end of June. Read: Fauci Says World Shares Blame For India’s COVID Crisis By Failing To Coordinate Global Response To Pandemic